AxoSim Empowers Advancements in Human Neuroscience
AxoSim is a biotechnology company that partners with pharmaceutical companies to foster innovation and facilitate breakthroughs in the treatment of the world’s most devastating neurodegenerative diseases. Drug discovery platforms NerveSim® and BrainSim® deliver clinically-relevant data to select better lead candidates with phenotypically accurate assays. NerveSim® offers a validated tissue model to predict drug neurotoxicity and human efficacy at earliest stages in drug development pipeline.